|
Merck Capital Ventures has made investments in the companies listed
below.
For more information about these companies follow the link to their web
site or go to their press release.
Acurian
Acurian Inc. provides pharmaceutical and
biotechnology companies with the most comprehensive informatics base from
which to launch a trial. Using Web-enabled and traditional tools, Acurian can strategically plan and implement
recruitment, document exchange and site support to compress the clinical
trial start-up phase.
Go to Acurian
Home Page | View
latest press releases for Acurian
Aegis Analytical Corporation
Aegis Analytical Corporation is the leading provider of
Manufacturing Informatics software systems for pharmaceutical,
biotechnology, food, natural products, specialty chemical and medical
device manufacturers. Customers use Aegis' Discoverant
software system to dramatically improve the profitability, stability and
regulatory compliance of their manufacturing processes.
Go to Aegis Analytical Home Page
| View
latest press releases for Aegis Analytical
Cytel
Cytel Software Corporation provides
statistical software and services for clinial
trial simulation, design and analysis. The company provides expertise in
applying advanced, validated statistical methods to optimize clinical
trials for the Bio/Pharmaceutical industry.
Go to Cytel Home Page | View latest press
releases for Cytel
High Throughput Genomics
HTG provides qNPA technology
and services for the life sciences industry, addressing current unmet needs
and enabling a new era of drug discovery and diagnostics. The company's
technology platform enables the accurate, sensitive, reproducible and
repeatable measurement of molecular signatures through the multiplexed
measurement of RNA expression levels, DNA and protein levels and function. qNPA data measure how drugs
act and diseases are mediated at the level of whole cells, tissues, or
organisms.
Go to HTG Home Page | View latest
press releases for HTG
Nano Imaging Services
NIS provides transmission electron microscopy (TEM) imaging services to the pharmaceutical, biotechnology and nanotechnology industries. The company has developed leading methodologies in cryo-TEM that delivers high resolution, three-dimensional images at the molecular level of specimens in their natural state.
.
Go to NIS Corporation Home Page | View latest press releases for NIS
ImpactRx
Founded in October of 2000, the Impact
Network is the source of an unprecedented intelligence capability for
tracking the promotional initiatives of the pharmaceutical industry in
real-time and measuring their effectiveness by linking this activity to the
prescribing behavior of physicians. Based in Mount Laurel, New Jersey,
ImpactRx is the nation’s first Promotion Research
Organization (PRO) for the pharmaceutical industry. With a proprietary
network currently comprised the nation’s highest-prescribing physicians, ImpactRx is the sole source of physician level data
that directly links the impact of physician promotion on prescribing
behavior. This new generation of market intelligence provides
pharmaceutical companies with the decision support needed to make important
strategic choices about the mix, timing and degree of promotional efforts.
Go to ImpactRx
Home Page | View
latest press releases for ImpactRx
MedCases
MedCases is a medical education
e-learning company and ACCME-accredited provider of continuing medical
education (CME). We develop and execute high-quality, peer-reviewed
clinical educational programs using interactive simulated patient
encounters. MedCases uses a proprietary,
Internet-based system to deliver comprehensive, cost-effective learning
with applications for practicing physicians, pharmaceutical companies,
academic medical centers, and health care delivery organizations
Go to MedCases
Home Page | View
latest press releases for MedCases
PHT Corporation
PHT Corporation provides pharmaceutical
companies, CROs, biotechnology firms, and medical
device companies with web-based software, infrastructure, and services for
the collection and processing of clinical trial data. PHT's
Esendant™ Clinical Network is a Web-based,
electronic data capture (EDC) and data management system that features a
revolutionary open architecture design based on an XML platform.
Go to PHT Corporation Home Page | View latest press releases
for PHT Corporation
VisEn Medical
VisEn
Medical is a leading developer imaging technologies in real-time molecular
mapping of disease states in vivo in research and drug development. The Company's technology platforms were
developed at the Massachusetts General
Hospital's Center for Molecular
Imaging Research and Harvard
Medical School's. The Company's FMT System and Optical
Probe Portfolio provide quantifiable molecular imaging of disease
progression and pharmaceutical activity in animals.
Go to VisEn Medical Home Page | View latest press
releases for VisEn
|